Bayer and Regeneron start MYRROR Phase III Trial
- Details
- Category: Bayer

Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
- Details
- Category: Amgen

GlaxoSmithKline announces Q4 2010 legal charge
- Details
- Category: GlaxoSmithKline

European Commission Clears Acquisition of Genzyme Corporation by sanofi-aventis
- Details
- Category: Sanofi

Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance
- Details
- Category: Boehringer Ingelheim

Sandoz announces phase II clinical trial for biosimilar version of rituximab
- Details
- Category: Novartis

GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK'786
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- New Bayer U.S. Innovation Center starts its operations
- People to Actively Manage Their Type 2 Diabetes
- Genzyme Financial Recovery Continues in Fourth Quarter
- Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse®
- Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold
- Genzyme Statement on Discussions With Sanofi-Aventis
- US Food and Drug Administration extend review timeline for vandetanib